Emerge Ventures, Singapore
3
1M
3
0.27
- Areas of investment
Summary
Emerge Ventures, Singapore appeared to be the VC, which was created in 2011.
The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2014.
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are Vidinovo, Papillon Capital LLC. In the next rounds fund is usually obtained by Sequoia Capital India, Zodius Capital, Sofina.
Among the most popular portfolio startups of the fund, we may highlight MedGenome Inc.. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Medical.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.27
- Investments by industry
- Medical (2)
- Health Care (2)
- Health Diagnostics (1)
- Genetics (1)
- Biotechnology (1) Show 2 more
- Investments by region
-
- India (2)
- United Arab Emirates (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Impact Hub Dubai | 11 Jun 2013 | Early Stage Venture | Dubai, United Arab Emirates |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.